E-LIB Suche - Ergebnisse für: Michel Laverdiere

1

Clinical Research in the Lay Press: Irresponsible Journalis..:

Elias J. Anaissie ; Brahm H. Segal ; John R. Graybill...
Clinical Infectious Diseases. 43 (2006) 8 - p. 1031-1039 , 2006

Link: https://www.jstor.org/st..

2

Antifungal Therapy Decreases Sensitivity of the Aspergillus..:

Kieren A. Marr ; Michel Laverdiere ; Anja Gugel.
Clinical Infectious Diseases. 40 (2005) 12 - p. 1762-1769 , 2005

Link: https://www.jstor.org/st..

3

A Double-Blind, Randomized, Controlled Trial of Amphoterici..:

Raleigh Bowden ; Pranatharthi Chandrasekar ; Mary H. White...
Clinical Infectious Diseases. 35 (2002) 4 - p. 359-366 , 2002

Link: https://www.jstor.org/st..

4

A Nosocomial Outbreak of Fluoroquinolone-Resistant Streptoc..:

Karl Weiss ; C. Restieri ; Richard Gauthier...
Clinical Infectious Diseases. 33 (2001) 4 - p. 517-522 , 2001

Link: https://www.jstor.org/st..

5

Randomized Placebo-Controlled Trial of Fluconazole Prophyla..:

Coleman Rotstein ; Eric J. Bow ; Michel Laverdiere...
Clinical Infectious Diseases. 28 (1999) 2 - p. 331-340 , 1999

Link: https://www.jstor.org/st..

6

Species distribution and antifungal susceptibility of invas..:

Fuller, Jeff ; Dingle, Tanis C ; Bull, Amy...
Journal of Antimicrobial Chemotherapy. 74 (2019) Supplement_4 - p. iv48-iv54 , 2019

Link: https://doi.org/10.1093/..

7

Risk factors for the development of Clostridium difficile i..:

Lavallée, Christian ; Labbé, Annie‐Claude ; Talbot, Jean‐Daniel...
Transplant Infectious Disease. 19 (2017) 1 - p. , 2017

Link: https://doi.org/10.1111/..

8

Phase 3 pharmacokinetics and safety study of a posaconazole..:

Waskin, Hetty ; Connelly, Nancy ; Van Iersel, Marlou...
Journal of Antimicrobial Chemotherapy. 71 (2016) 6 - p. 1747-1747 , 2016

Link: https://doi.org/10.1093/..

9

High frequency of pathogenicAspergillusspecies among nonspo..:

Dufresne, Philippe J. ; Moonjely, Soumya S. ; Ozaki, Koyomi...
Medical Mycology. 55 (2016) 2 - p. 233-236 , 2016

Link: https://doi.org/10.1093/..

10

Guidance for Practitioners on the Use of Antiviral Drugs to..:

Aoki, Fred Y ; Allen, Upton D ; Stiver, H Grant...
Canadian Journal of Infectious Diseases and Medical Microbiology. 26 (2015) 1 - p. e1-e4 , 2015

Link: https://doi.org/10.1155/..

11

Phase 3 pharmacokinetics and safety study of a posaconazole..:

Cornely, Oliver A. ; Duarte, Rafael F. ; Haider, Shariq...
Journal of Antimicrobial Chemotherapy. 71 (2015) 3 - p. 718-726 , 2015

Link: https://doi.org/10.1093/..

12

Guidance on The Use of Antiviral Drugs for Influenza in Acu..:

Stiver, H Grant ; Evans, Gerald A ; Aoki, Fred Y..
Canadian Journal of Infectious Diseases and Medical Microbiology. 26 (2015) 1 - p. e5-e8 , 2015

Link: https://doi.org/10.1155/..

13

Sporadic Community-Acquired Legionnaires' Disease and Conta..:

, In: Legionella,

Laverdière, Michel ; Joly, Jean R. ; Habel, Francine... - p. 360-363 , 2014

Link: https://doi.org/10.1128/..

14

The Prospective Antifungal Therapy Alliance®Registry: A Two..:

Haider, Shariq ; Rotstein, Coleman ; Horn, David..
Canadian Journal of Infectious Diseases and Medical Microbiology. 25 (2014) 1 - p. 17-23 , 2014

Link: https://doi.org/10.1155/..

15

Therapeutic drug monitoring for triazoles: A needs assessme..:

Laverdiere, Michel ; Bow, Eric J ; Rotstein, Coleman...
Canadian Journal of Infectious Diseases and Medical Microbiology. 25 (2014) 6 - p. 327-343 , 2014

Link: https://doi.org/10.1155/..